Analysis of radiation-induced liver disease using the Lyman NTCP model
Dawson L.A., Normolle D., Balter J.M., et al. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 53 (2002) 810-821
Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus
Ishikura S., Ogino T., Furuse J., et al. Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Clin Oncol 25 (2002) 189-193
Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma
Yamada K., Izaki K., Sugimoto K., et al. Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 57 (2003) 113-119
Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement
Tazawa J., Maeda M., Sakai Y., et al. Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement. J Gastroenterol Hepatol 16 (2001) 660-665
Surgical treatment strategy for patients with Stage 4 hepatocellular carcinoma
Shimada M., Takenaka K., Kawahara N., et al. Surgical treatment strategy for patients with Stage 4 hepatocellular carcinoma. Surgery 119 (1996) 517-522
Surgical intervention for patients with Stage 4-A hepatocellular carcinoma without lymph nodes metastasis. Proposal as a standard therapy
Ikai I., Yamaoka Y., Yamamoto Y., et al. Surgical intervention for patients with Stage 4-A hepatocellular carcinoma without lymph nodes metastasis. Proposal as a standard therapy. Ann Surg 227 (1998) 433-439
Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma
Xu Z.Y., Liang S.X., Zhu J., et al. Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma. Int J Radiat Oncol Biol Phys 65 (2006) 189-195
Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: Dosimetric analysis and implication
Cheng J.C.H., Wu J.K., Huang C.M., et al. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: Dosimetric analysis and implication. Int J Radiat Oncol Biol Phys 54 (2002) 156-162
A quantitative model of technetium-99m-DTPA-galactosyl-HSA for the assessment of hepatic blood flow and hepatic binding receptor
Ha-Kawa S.K., and Tanaka Y. A quantitative model of technetium-99m-DTPA-galactosyl-HSA for the assessment of hepatic blood flow and hepatic binding receptor. J Nucl Med 32 (1991) 2233-2240
Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium-99m-galactosyl-human serum albumin (TcGSA)
Kudo M., Toda A., Ikekubo K., et al. Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium-99m-galactosyl-human serum albumin (TcGSA). Hepatology 17 (1993) 814-819
Local radiotherapy for patients with unresectable hepatocellular carcinoma
Park W., Lim D.H., Paik S.W., et al. Local radiotherapy for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 1143-1150
Dose-response relationship in local radiotherapy for hepatocellular carcinoma
Park H.C., Seong J., Han K.H., et al. Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 54 (2002) 150-155
Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma
Wang D., Schultz C.J., Jursinic P.A., et al. Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 65 (2006) 143-151
Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer
Madani I., Duthoy W., Derie C., et al. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 68 (2007) 126-135